GBL

GBL recorded a decline in NAV per share in H1 2025 from €115.15 to €107.75, but achieved a total shareholder return of 16.1%. The company raised the dividend by 82% to €5.00 per share, carried out share buybacks totaling €170 million and cancelled 5.2 million shares. Performance was driven mainly by direct private-equity investments in the healthcare sector (Affidea, Sanoptis), which made a substantial positive contribution; Canyon, however, suffered from falling revenues. GBL remains financially conservative with low leverage (LTV 1.6%) and €4.8 billion in liquidity and plans to mobilize around €7 billion between 2024 and 2027 to finance further private investments and distributions. » More on de.investing.com

Roman Arnold will resume an operational leadership role at Canyon from 1 September to shape strategy and the company’s future course. Nicolas de Ros Wallace is stepping down as CEO after three and a half years; during his tenure revenue doubled, but recalls, quality issues and heavy losses weighed on the company. According to majority shareholder GBL, Canyon posted a net loss of €38 million in 2024 and remains in the red for 2025 for the time being. » More on manager-magazin.de

The bicycle industry is battling oversupply and discounting, but the road and gravel bike segment continues to grow and is driving demand. Canyon reports increased interest in its models, while retailers like Lucky Bike are responding with clearance sales and investor GBL notes a difficult market environment. » More on rnd.de